Loading...
XHEL
REG1V
Market cap504mUSD
Aug 28, Last price  
14.98EUR
Name

Revenio Group Oyj

Chart & performance

D1W1MN
XHEL:REG1V chart
P/E
25.05
P/S
3.97
EPS
0.60
Div yield, %
2.67%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
12.43%
Revenues
Net income
CFO
Dividend
Apr 11, 20250.4 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Revenio Group Oyj operates as a healthcare technology company, specializing in the development, production, and global distribution of advanced ophthalmic diagnostic instruments and medical devices. These innovations are engineered to aid in the identification of various eye conditions, including glaucoma, macular degeneration, diabetic retinopathy, and cataracts, serving clientele in Finland, throughout Europe, and worldwide. Its extensive product portfolio includes the iCare IC100 and IC200 tonometers, along with the iCare HOME device for personal eye pressure monitoring. Furthermore, the company provides sophisticated imaging technologies such as the iCare EIDON AF for confocal retinal imaging, DRSplus for screening diabetic retinopathy, the iCare MAIA microperimeter for precise visual field measurements, and iCare COMPASS, which facilitates fundus perimetry using true-color retinal images. Beyond hardware, Revenio also offers Oculo, a comprehensive eye care software platform that seamlessly integrates clinical communication, telehealth functionalities, remote patient monitoring, and robust data analytics. Established in 2001, Revenio Group Oyj is based in Vantaa, Finland.
IPO date
Jan 01, 2003
Employees
217
Domiciled in
FI
Incorporated in
FI

Valuation

No data to show